Amedeo's Top 20

Amedeo Smart

Independent Medical Education


12 November 2012

Multidisciplinary Journal Club

  1. Jakola AS , Myrmel KS, Kloster R, Torp SH, et al.
    Comparison of a Strategy Favoring Early Surgical Resection vs a Strategy Favoring Watchful Waiting in Low-Grade Gliomas.
    JAMA 2012.

  1. Joosten MM , Pai JK, Bertoia ML, Rimm EB, et al.
    Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men.
    JAMA 2012;308:1660-7.

  2. Roth EM , McKenney JM, Hanotin C, Asset G, et al.
    Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia.
    N Engl J Med 2012.

  3. Theeler BJ , Yung WK, Fuller GN, De Groot JF, et al.
    Moving toward molecular classification of diffuse gliomas in adults.
    Neurology 2012;79:1917-26.

  4. Dupuis J , Berriolo-Riedinger A, Julian A, Brice P, et al.
    Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography Response Evaluation in Patients With High-Tumor Burden Follicular Lymphoma Treated With Immunochemotherapy: A Prospective Study From the Groupe d'Etudes des Lymphomes de l'
    J Clin Oncol 2012.

  1. Banks PA , Bollen TL, Dervenis C, Gooszen HG, et al.
    Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus.
    Gut 2012.

  2. John RM , Tedrow UB, Koplan BA, Albert CM, et al.
    Ventricular arrhythmias and sudden cardiac death.
    Lancet 2012;380:1520-9.

  3. Boonen S , Reginster JY, Kaufman JM, Lippuner K, et al.
    Fracture risk and zoledronic acid therapy in men with osteoporosis.
    N Engl J Med 2012;367:1714-23.

  4. Klein F , Halper-Stromberg A, Horwitz JA, Gruell H, et al.
    HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.
    Nature 2012.

  5. Ardizzoni A , Tiseo M, Boni L, Vincent AD, et al.
    Pemetrexed Versus Pemetrexed and Carboplatin As Second-Line Chemotherapy in Advanced Non-Small-Cell Lung Cancer: Results of the GOIRC 02-2006 Randomized Phase II Study and Pooled Analysis With the NVALT7 Trial.
    J Clin Oncol 2012.

  1. Rigau V , Mania A, Befort P, Carlander B, et al.
    LETHAL MULTIPLE SCLEROSIS RELAPSE AFTER NATALIZUMAB WITHDRAWAL.
    Neurology 2012.

  2. Dignan FL , Clark A, Amrolia P, Cornish J, et al.
    Diagnosis and management of acute graft-versus-host disease.
    Br J Haematol 2012;158:30-45.

  3. Molassiotis A , Bardy J, Finnegan-John J, Mackereth P, et al.
    Acupuncture for Cancer-Related Fatigue in Patients With Breast Cancer: A Pragmatic Randomized Controlled Trial.
    J Clin Oncol 2012.

  4. Chojnacki J , Staudt T, Glass B, Bingen P, et al.
    Maturation-dependent HIV-1 surface protein redistribution revealed by fluorescence nanoscopy.
    Science 2012;338:524-8.

  5. Paietta E .
    When it comes to MRD, AML not equal ALL.
    Blood 2012;120:1536-7.

  1. Niedowicz DM , Beckett TL, Matveev S, Weidner AM, et al.
    Pittsburgh compound B and the postmortem diagnosis of alzheimer disease.
    Ann Neurol 2012;72:564-70.

  2. Sorensen AT , Kokaia M.
    Novel approaches to epilepsy treatment.
    Epilepsia 2012.

  3. Rothe A , Sasse S, Goergen H, Eichenauer DA, et al.
    Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience.
    Blood 2012;120:1470-2.

  4. Holland PR , Akerman S, Andreou AP, Karsan N, et al.
    Acid-sensing ion channel 1: A novel therapeutic target for migraine with aura.
    Ann Neurol 2012;72:559-63.

  5. Dignan FL , Amrolia P, Clark A, Cornish J, et al.
    Diagnosis and management of chronic graft-versus-host disease.
    Br J Haematol 2012;158:46-61.


more..


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016